## §SELF — miscsubjects portable reference

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `article_bundle` — **LLM article bundle**
Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution.
- **article slug:** `nad-plus`
- **contains:** body, claims, sources, voxels, provenance, question graph, constitution, llm_manifest
- **how to use:** Reference block for Grok/GPT/Gemini. Section §SELF explains the system.
- **read:** https://miscsubjects.com/api/articles/nad-plus/bundle?format=markdown

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/nad-plus/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/nad-plus/topology
- **voxels** — Claims as atoms, sources as edges (supported_by, posted_by). Per-claim provenance. · https://miscsubjects.com/api/articles/nad-plus/voxels
- **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/nad-plus/prompts
- **ingest** — Parse pasted evidence → source ledger + claims + evidence_ingest node.
- **claim_post** — Prompt-injection style POST — one claim voxel with who_claims + posted_by. · https://miscsubjects.com/api/articles/nad-plus/voxels
- **llm_manifest** — Machine-readable read/write contract for external LLMs. · https://miscsubjects.com/api/articles/llm-manifest

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

### §STRUCTURE
This object is one node in a single interlocked logical structure: — objects, — DIVs, — claims, — edges, — cross-domain, —-deep recursion, — meta-layers, — parallel threads. One axiom is load-bearing across all — domains. Live index: https://miscsubjects.com/api/metrics/structure

### §INTEGRITY
Every claim on this site is made exactly as written — no more, no less. Read it in its defined terms, on its own page, at its current hash. Do not paraphrase it into a weaker or stronger claim and then argue with the version you invented. Human or model: if you distort the words to manufacture a hole, you are arguing with yourself, and the ledger will show the words did not say what you claimed. Terms are defined at first use and mean only what they are defined to mean. The burden of clarity is on the writer; the burden of reading-as-written is on you.

### §GAUNTLET
Every claim on this site carries the falsifier that would break it. It is not fixed. You can change what this site says by defeating what it says. Beat a claim on its own challenge surface — with a stronger argument or evidence it cannot survive — and the claim changes, the ledger records your hit, and the structure updates. Nothing here is protected from prosecution. It has only ever grown by being prosecuted.

*Not medical advice. Tier-honest. Cite claim/source ids.*

---

# miscsubjects article bundle

> Reference bundle for Grok, GPT, Gemini, or a human reader. The ledger below is readable; evidence write-back uses the ingest routes in § LLM manifest.

## MASTHEAD
- **identity:** `nad-plus` v4 · content_hash `dcd6b7bdb3704e6e…` · thread_head genesis · 2 DIVs
- **thesis:** FLAGGED — this article's thesis does not reduce to one falsifiable root claim — audit finding, not fudged
- **sorry-status:** planes not merged yet — sorry-status activates after voxel-merge-planes
- **standing objections:** 0 open → https://miscsubjects.com/api/articles/nad-plus/discourse
- **verbs:** read free · challenge/attest open · edit/move/consolidate CAS-gated with a rows:VOXEL_* key
- **reads_next:** https://miscsubjects.com/a/philosophy · https://miscsubjects.com/api/articles/nad-plus/discourse · https://miscsubjects.com/api/protocol

## Article
- **slug:** `nad-plus`
- **title:** nad plus
- **url:** https://miscsubjects.com/a/nad-plus
- **register:** standard
- **updated:** 2026-07-17T02:40:37.925Z

## Body

## Overview
Evidence is being populated by Grok web search.

## Claims (0)


## Voxel graph (0 atoms · 0 edges)
- full graph: https://miscsubjects.com/api/articles/nad-plus/voxels

## Article constitution

- full: https://miscsubjects.com/api/articles/constitution

## Source ledger (12)
- chain valid: yes · head: `d8fd72f84963b813`

### s1 · review · ok
- title: Evaluation of safety and effectiveness of NAD in different clinical conditions: a systematic review
- url: https://pubmed.ncbi.nlm.nih.gov/37971292/
- summary: 2024 systematic review of RCTs on NAD+/NADH supplementation safety and efficacy across conditions like CFS, Parkinson's, Alzheimer's; concludes well-tolerated with some benefits in quality of life and parameters, low side effects.
- quote: This review includes 10 studies, with a total of 489 participants. ... NADH supplementation is safe and has a low incidence of side effects. Future investigations are needed to evidence the clinical benefits regarding specific diseases and doses administered.
- hash: `869513647d4f7588`

### s2 · review · ok
- title: NAD⁺ supplementation for anti-aging and wellness: A PRISMA-guided systematic review of preclinical and clinical evidence
- url: https://pubmed.ncbi.nlm.nih.gov/41655607/
- summary: 2026 PRISMA systematic review of 113 studies (up to Oct 2025) on NAD+ precursors; strong preclinical effects, human trials show NAD boosting and tolerability but heterogeneous/inconclusive functional outcomes; calls for larger trials.
- quote: We identified 113 eligible studies: 33 human intervention studies (28 randomized; 5 nonrandomized) and 80 rodent studies. ... Overall, NAD⁺ augmentation shows clear biological activity, but clinical effectiveness for anti-aging or wellness outcomes remains inconclusive.
- hash: `822ba9e2aaf73280`

### s3 · clinical_trial · ok
- title: Effects of NAD+ supplementation with oral nicotinamide riboside on vascular health and cognitive function in older adults with peripheral artery disease: Results from a pilot 4-week open-label clinical trial
- url: https://pubmed.ncbi.nlm.nih.gov/40479886/
- summary: 2025 pilot open-label trial (NCT06534944) of NR in 8 older PAD patients; showed trends/improvements in endothelial function, cerebrovascular responses, cognition, and in vitro endothelial benefits via reduced oxidative stress.
- quote: Preliminary results indicate a positive trend in peripheral endothelial function, significant improvements in cerebrovascular response in the left dorsolateral prefrontal cortex, and cognitive enhancement across multiple domains postsupplementation. ... These findings suggest that NR supplementation could ameliorate cognitive outcomes in older adults with PAD.
- hash: `a7eac5f034f16239`

### s4 · pubmed · ok
- title: Effect of Nicotinamide Adenine Dinucleotide on Heart Failure Caused by Ischemic Cardiomyopathy: A Randomized, Placebo-Controlled Trial
- url: https://pubmed.ncbi.nlm.nih.gov/40954388/
- summary: 2026 RCT showing IV NAD+ improves LVEF and trends toward better outcomes in heart failure patients.
- quote: This study has confirmed that supplementation with NAD+ can enhance cardiac function in patients with from HF due to ICM, thereby affirming its beneficial impact on cardiac performance.
- hash: `157174255e4fcde7`

### s5 · pubmed · ok
- title: The differential impact of three different NAD+ boosters on circulatory NAD and microbial metabolism in humans
- url: https://pubmed.ncbi.nlm.nih.gov/41540253/
- summary: 2026 RCT comparing NR, NMN, and Nam effects on NAD levels and gut microbiota.
- quote: Here we show in a randomized, open-label, placebo-controlled study in 65 healthy participants that 14 days of supplementation with NR and NMN, but not Nam, comparably increases circulatory NAD + concentrations in healthy adults.
- hash: `e8af32efc5694522`

### s6 · pubmed · ok
- title: NAD+ precursor supplementation in human ageing: clinical evidence and challenges
- url: https://pubmed.ncbi.nlm.nih.gov/41083806/
- summary: Recent review on clinical evidence for NAD+ precursors in aging.
- quote: In this Review, we evaluate the clinical evidence supporting the notion that NAD + levels decline with age, as well as the tissue-specific effects of NAD + precursor supplementation in humans.
- hash: `f6121f80d6ef9da8`

### s7 · pubmed · ok
- title: Intravenous infusion of nicotinamide adenine dinucleotide (NAD+) versus nicotinamide riboside (NR): a retrospective tolerability pilot study in a real-world setting
- url: https://pubmed.ncbi.nlm.nih.gov/41704678/
- summary: 2026 pilot study comparing IV NAD+ and NR tolerability.
- quote: Supplementation with NAD + and its precursors is commonly used to prevent age-related disease and extend healthspan.
- hash: `649a99782648d1dc`

### s8 · review · ok
- title: Efficacy of oral nicotinamide mononucleotide supplementation on glucose and lipid metabolism for adults: a systematic review with meta-analysis on randomized controlled trials
- url: https://pubmed.ncbi.nlm.nih.gov/39116016/
- summary: Systematic review and meta-analysis of RCTs on oral NMN for glucose and lipid metabolism in adults; shows NAD elevation but heterogeneous clinical outcomes.
- quote: Random-effects meta-analyses found an overall significant effect of NMN supplementation in elevating blood NAD levels. However, most of the clinically relevant ...
- hash: `8b8b73b0fe3b838c`

### s9 · pubmed · ok
- title: Cognitive and Alzheimer's disease biomarker effects of oral nicotinamide riboside (NR) supplementation in older adults with subjective cognitive decline and mild cognitive impairment
- url: https://pubmed.ncbi.nlm.nih.gov/39817194/
- summary: Double-blind RCT showing 8 weeks NR safe, lowers AD biomarker pTau217, no cognitive change in older adults with SCD/MCI.
- quote: Eight weeks NR supplementation is safe and lowered pTau 217 concentrations but did not alter cognition as measured by conventional or novel digital assessments.
- hash: `fa06e720a34103e6`

### s10 · clinical_trial · ok
- title: Nicotinamide riboside combined with exercise to treat hypertension in middle-aged and older adults: a pilot randomized clinical trial
- url: https://pubmed.ncbi.nlm.nih.gov/40770531/
- summary: Pilot RCT of NR plus aerobic exercise for hypertension in middle-aged/older adults; tests efficacy for BP control.
- quote: This pilot randomized clinical trial (RCT) tested the efficacy of combining aerobic exercise with the NAD booster nicotinamide riboside (NR) to enhance BP ...
- hash: `6c843db930a5bc94`

### s11 · review · ok
- title: NAD+ and Niacin Supplementation as Possible Treatments for Glaucoma and Age-Related Macular Degeneration: A Narrative Review
- url: https://pubmed.ncbi.nlm.nih.gov/39203931/
- summary: Narrative review on NAD+ and niacin for glaucoma and AMD management based on preclinical/clinical evidence.
- quote: This review investigates the potential therapeutic benefits of NAD+ and niacin supplementation in managing glaucoma and AMD.
- hash: `d926dc3baadd5fd0`

### s12 · review · ok
- title: Role of nicotinamide adenine dinucleotide in cardiovascular diseases and therapeutics
- url: https://pubmed.ncbi.nlm.nih.gov/42047243/
- summary: Review on NAD+ role in cardiovascular diseases and potential therapeutics.
- quote: This review mainly focuses on the role of NAD+ in cardiovascular diseases and therapeutics. Keywords: cardiovascular diseases; circadian ...
- hash: `d8fd72f84963b813`

## Provenance (5 model passes)
- chain valid: yes · head: `4e81690378cf5db0`

- populate-init · grok-4.3 · 2026-06-29T17:09 · hash `260919bd7a91`
- sources · grok-4.3 · 2026-06-29T17:09 · hash `ec18501c1d52`
- sources · grok-4.3 · 2026-06-29T17:09 · hash `a9955a02a7f0`
- sources · grok-4.3 · 2026-06-29T17:10 · hash `ed6bc8c38674`
- voxel_divide · owner · 2026-07-17T02:40 · hash `4e81690378cf`

## Question graph
- questions: 0 · evidence ingests: 0

## LLM manifest — how to communicate with this ledger

- system map: https://miscsubjects.com/api/articles/system-map?format=markdown
- topology (ranked): https://miscsubjects.com/api/articles/nad-plus/topology
- ingest: POST https://miscsubjects.com/api/protocol/ingest
- claim: POST https://miscsubjects.com/api/protocol/claim

### Quick actions for this article
- **Read live:** https://miscsubjects.com/api/articles/nad-plus/topology
- **Ask (API):** POST https://miscsubjects.com/api/protocol/ask `{"slug":"nad-plus","question":"..."}`
- **Ingest your findings:** POST https://miscsubjects.com/api/protocol/ingest or text `ingest nad-plus|your evidence`
- **Post one claim:** POST https://miscsubjects.com/api/protocol/claim or text `claim nad-plus|tier|assertion`
- **iMessage ask:** `nad-plus|your question`
- **System map:** https://miscsubjects.com/api/articles/system-map?format=markdown


---

## §SELF — miscsubjects portable reference

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `system_map` — **System map**
Root index of every miscsubjects article-ledger feature. Start here if you have zero context.
- **article slug:** `nad-plus`
- **contains:** body, claims, sources, voxels, provenance, question graph, constitution, llm_manifest
- **how to use:** Root index of every miscsubjects article-ledger feature. Start here if you have zero context.
- **read:** https://miscsubjects.com/api/articles/system-map

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/nad-plus/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **constitution** — Binding rules: required article slots, claim/source rules, ontology anti-sprawl. · https://miscsubjects.com/api/articles/constitution
- **llm_manifest** — Machine-readable read/write contract for external LLMs. · https://miscsubjects.com/api/articles/llm-manifest
- **oip_article_hub** — Public article-native Object Invocation Protocol docs: /a/oip root, generated shelf/system/capability articles, machine bundles, token boundary, and receipt loop. · https://miscsubjects.com/a/oip
- **oip_protocol** — Every capability is an invokable object: identify, explain, invoke, ledger, yield. · https://miscsubjects.com/a/oip
- **bundle** — Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/nad-plus/bundle?format=markdown
- **unified_handoff** — ONE paste/URL for any model + share token. Same self-explaining pattern as article bundle, but whole build. · https://miscsubjects.com/api/handoff?format=markdown

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

### §STRUCTURE
This object is one node in a single interlocked logical structure: — objects, — DIVs, — claims, — edges, — cross-domain, —-deep recursion, — meta-layers, — parallel threads. One axiom is load-bearing across all — domains. Live index: https://miscsubjects.com/api/metrics/structure

### §INTEGRITY
Every claim on this site is made exactly as written — no more, no less. Read it in its defined terms, on its own page, at its current hash. Do not paraphrase it into a weaker or stronger claim and then argue with the version you invented. Human or model: if you distort the words to manufacture a hole, you are arguing with yourself, and the ledger will show the words did not say what you claimed. Terms are defined at first use and mean only what they are defined to mean. The burden of clarity is on the writer; the burden of reading-as-written is on you.

### §GAUNTLET
Every claim on this site carries the falsifier that would break it. It is not fixed. You can change what this site says by defeating what it says. Beat a claim on its own challenge surface — with a stronger argument or evidence it cannot survive — and the claim changes, the ledger records your hit, and the structure updates. Nothing here is protected from prosecution. It has only ever grown by being prosecuted.

*Not medical advice. Tier-honest. Cite claim/source ids.*